Aarti IndustriesQ1 FY27
Aarti Industries Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹539P/E: 36.6Market Cap: ₹19.1K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Steady volume growth is expected, supported by capacity expansion and deeper market penetration.
- →Despite short-term export headwinds due to the West Asia conflict, underlying demand remains robust across most end markets.
- →Fuel additives capacity expanded to 360 KTPA and is expected to reach high utilization soon, with potential to increase further post-stabilization.
- →Non-energy segments like polymers and agrochemicals are anticipated to recover volume in Q2 after seasonal and pricing pressures.
- →New platforms like battery chemicals and defense applications are being explored based on capability and return profiles.
- →JV operations (e.g., Augene Chemicals) are ramping up, contributing to future revenue growth.
- →FY27 capex is on track at Rs. 700-800 crore with reduced intensity expected after major expansions complete.
- →FY28 target EBITDA of Rs. 1800 crore includes contribution from JV operations, reflecting confidence in growth trajectory.
Margin guidance
Category 3- →Aarti Industries targets EBITDA of INR 1,800 crore by FY28, including contributions from the Augene JV.
- →Growth is expected from volume recovery and capacity expansions, particularly in fuel additives (360 KTPA capacity).
- →Zone IV project, despite 3-6 months delay, is expected to commission in phases with ramp-up over FY28 and FY29.
- →Non-energy segments like polymers and pharma show stable to strong demand; dyes and pigments likely to recover.
- →Margin trajectory may normalize post volatile raw material and forex impacts; business runs on absolute delta margins.
- →Future capex will focus on high-growth, high-return niche projects with lower overall CAPEX intensity from FY28.
- →New markets and products (battery chemicals, defense) selected based on competitiveness, scalability, and returns.
- →JVs and downstream initiatives (Augene, Re Sustainability) expected to add value from FY27 onwards.
3 more insights locked — sign up free to unlock
Fundraise plans
- →No explicit mention of any current or future fundraising through debt or equity in the provided transcript.
- →The company discussed ongoing and planned capital expenditures (CAPEX) for FY27 in the range of Rs. 700 to 800 crore.
- →Major expansion programs are nearing completion, and CAPEX intensity is expected to reduce starting next year.
- →Future capital deployment will focus on high-growth, high-return niche projects.
- →No direct reference to raising funds via debt or equity was stated during the call or in the management's discussion.
Order book
The transcript does not provide specific details on the current or expected order book or pending orders. However, related insights include:
- The company has a strong export order flow, with 59% of revenue from exports in the quarter.
- There is increased traction in exports, especially to longer destinations like the U.S. and Americas.
- The management is focused on diversifying volumes across geographies to balance market exposure.
- Volume growth visibility is strong, particularly in the energy business.
- For specialized products like ethylated intermediates and fuel additives, contracts such as a USD 150 million contract with an innovator indicate long-term opportunities.
- Market development for new products like MMA is ongoing with phased adoption, implying an active new order pipeline.
No explicit quantitative figures on orderbook or pending orders were disclosed.
Capex plans
Yes- →Zone IV project expansion is ongoing with 3-6 months delay due to labor and war-related issues; commissioning is phased over FY27 with ramp-up in FY28 and FY29.
- →FY27 CAPEX is on track within Rs. 700-800 crore range, with Rs. 180 crore deployed in Q1FY27.
- →Future capital deployment will focus on high-growth, high-return niche projects, reducing CAPEX intensity starting FY28.
- →Debottlenecking of DCB capacity to 140 KTPA planned, supported by demand for PDCB and downstream products.
- →JV with Superform Chemistries (Augene Chemicals) is on track for commissioning in Q2FY27, focusing on specialty chemicals.
- →Plastic recycling initiative with Re Sustainability (Aarti Circularity) slated for commissioning in second half of FY27, emphasizing ESG and circularity.
- →Expansion through subsidiaries in UAE, UK, USA progressing; a new subsidiary planned in China to enhance market reach and sourcing efficiency.
How does Aarti Industries rank vs peers in Chemicals & Petrochemicals?
Pro feature1Aarti Industries
Rev 3Mar 3
See full Chemicals & Petrochemicals sector rankings
How does Aarti Industries rank in Chemicals & Petrochemicals?
Compare Aarti Industries against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.